[Management of psychotic drive disorders].
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy; D002749:Chlorprothixene / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004328:Drive; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010259:Paranoid Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D013881:Thioridazine / Q000627:therapeutic use; D014191:Tranylcypromine / Q000627:therapeutic use*; D014268:Trifluoperazine / Q000627:therapeutic use*
D014268:Trifluoperazine; D014191:Tranylcypromine; D002749:Chlorprothixene; D013881:Thioridazine; D007099:Imipramine; D003975:Diazepam; D005476:Fluphenazine
Die Behandlung psychotischer Antriebsstörungen.